119 related articles for article (PubMed ID: 12530060)
21. ICBP90 expression is downregulated in apoptosis-induced Jurkat cells.
Abbady AQ; Bronner C; Trotzier MA; Hopfner R; Bathami K; Muller CD; Jeanblanc M; Mousli M
Ann N Y Acad Sci; 2003 Dec; 1010():300-3. PubMed ID: 15033738
[TBL] [Abstract][Full Text] [Related]
22. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
23. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
24. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
[TBL] [Abstract][Full Text] [Related]
25. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
26. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
27. Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene.
Asano T; An T; Mayes J; Zwelling LA; Kleinerman ES
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):307-13. PubMed ID: 8870683
[TBL] [Abstract][Full Text] [Related]
28. Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Oncology; 2023; 101(7):457-468. PubMed ID: 37263260
[TBL] [Abstract][Full Text] [Related]
29. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
32. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells.
Fang Z; Xing F; Bronner C; Teng Z; Guo Z
Cell Immunol; 2009; 257(1-2):80-7. PubMed ID: 19328461
[TBL] [Abstract][Full Text] [Related]
33. The antiapoptotic protein ICBP90 is a target for protein kinase 2.
Bronner C; Trotzier MA; Filhol O; Cochet C; Rochette-Egly C; Schöller-Guinard M; Klein JP; Mousli M
Ann N Y Acad Sci; 2004 Dec; 1030():355-60. PubMed ID: 15659817
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the 3' untranslated region of mouse DNA topoisomerase IIalpha mRNA.
Kobayashi M; Adachi N; Koyama H
Gene; 1998 Jul; 215(2):329-37. PubMed ID: 9714832
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.
Yao J; Leng L; Sauler M; Fu W; Zheng J; Zhang Y; Du X; Yu X; Lee P; Bucala R
J Clin Invest; 2016 Feb; 126(2):732-44. PubMed ID: 26752645
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin and gamma rays increase the level of DNA topoisomerase IIalpha in nuclei of normal and xeroderma pigmentosum fibroblasts.
Thielmann HW; Popanda O
J Cancer Res Clin Oncol; 1998; 124(7):355-66. PubMed ID: 9719498
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene.
Ng SW; Liu Y; Schnipper LE
Gene; 1997 Dec; 203(2):113-9. PubMed ID: 9426241
[TBL] [Abstract][Full Text] [Related]
38. NF-M trans-activates the human DNA topoisomerase II alpha promoter independently of c-Myb in HL-60 cells.
Brandt TL; Kroll DJ
Leuk Res; 1997 Aug; 21(8):711-20. PubMed ID: 9379678
[TBL] [Abstract][Full Text] [Related]
39. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.
Woessner RD; Mattern MR; Mirabelli CK; Johnson RK; Drake FH
Cell Growth Differ; 1991 Apr; 2(4):209-14. PubMed ID: 1651102
[TBL] [Abstract][Full Text] [Related]
40. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation.
Zandvliet DW; Hanby AM; Austin CA; Marsh KL; Clark IB; Wright NA; Poulsom R
Biochim Biophys Acta; 1996 Jun; 1307(2):239-47. PubMed ID: 8679710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
